Ruxolitinib (INCB018424) (C007B-253895)

INCB018424 is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3.An inhibitor of JAK1, JAK2, and JAK3. Specification: ≥98% Molecular Formula: C17H18N6 Molecular Weight: 306.37 PubChem CID: 25126798 Isomeric SMILES: C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/R126338-SCI_ebefa63b559d13aa5a5486f396b9fcb8.pdf

UPC:

51112023

Condition:

New

Weight:

0.85 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

R126338-100mg

CAS:

941678-49-5

Product Size:

100mg